Company Filing History:
Years Active: 2005-2006
Title: Jürgen Hemberger: Innovator in Platelet Adhesion Inhibition
Introduction
Jürgen Hemberger is a notable inventor based in Aschaffenburg, Germany. He has made significant contributions to the field of biomedical research, particularly in the development of proteins that inhibit platelet adhesion. With a total of 2 patents, his work has implications for therapeutic treatments related to heart disease and circulation disorders.
Latest Patents
Hemberger's latest patents focus on a naturally occurring protein isolated from the saliva of the medicinal leech. This protein strongly binds to collagen, acting as an inhibitor of natural platelet adhesion to collagen. The protein has a molecular weight of about 12,000, an acidic isoelectric point, and contains six cysteines. The sequencing of the protein and cloning of its gene from a cDNA library have been accomplished. Procedures for producing this polypeptide through recombinant techniques are also disclosed. Both the recombinant and naturally occurring proteins serve as potent inhibitors of collagen-dependent platelet adhesion, making them useful for therapeutic treatments of various conditions related to heart disease and diseases of the circulatory system. Additionally, the protein can coat natural or artificial collagen surfaces, rendering them nonadhesive for cells and preventing cell activation.
Career Highlights
Throughout his career, Hemberger has worked with prominent companies in the pharmaceutical industry, including Merck Patent GmbH and Sanofi-Aventis Deutschland GmbH. His experience in these organizations has contributed to his expertise in the field of protein research and development.
Collaborations
Hemberger has collaborated with notable colleagues such as Wolfgang Strittmatter and Detlef Güssow. These partnerships have likely enhanced his research and innovation efforts.
Conclusion
Jürgen Hemberger's work in developing proteins that inhibit platelet adhesion showcases his innovative spirit and dedication to advancing medical science. His contributions have the potential to significantly impact therapeutic treatments for heart disease and related conditions.